It has been a long road to this point, shares with the latlest offreing have fallen to unprecidented low level, but Orbimed must think there is something to this play as they have invested heavily and control the company. Still looking for full time CEO and are hiring workers back. Last few days have shown some strength in the shares which are now .08 to .085, this is above the recent offering price. Another diagnostic company, Medmira - MIR, is it seems in a simiar position, lots of share dillution, with the principle investors gaining more control. Revenue for RBM is building, but is it building fast enough? All we can do is wait for news but the prospects for this company are improving.